Delayed-Action Preparations

"Delayed-Action Preparations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Dosage forms of a drug that act over a period of time by controlled-release processes or technology.

Descriptor ID	D003692
MeSH Number(s)	D26.255.210 E02.319.300.253
Concept/Terms	Delayed-Action Preparations Delayed-Action Preparations Delayed Action Preparations Delayed-Action Preparation Controlled-Release Preparations Controlled-Release Preparations Controlled Release Preparations Controlled-Release Preparation Controlled-Release Formulations Controlled Release Formulations Controlled-Release Formulation Sustained-Release Preparations Sustained-Release Preparations Sustained-Release Preparation Extended Release Preparations Extended Release Preparation Slow Release Formulation Sustained Release Formulations Sustained Release Formulation Extended Release Formulations Extended Release Formulation Timed-Release Preparations Timed-Release Preparations Timed Release Preparations Timed-Release Preparation Depot Preparations Depot Preparations Depot Preparation Prolonged-Action Preparations Prolonged-Action Preparations Prolonged-Action Preparation

Below are MeSH descriptors whose meaning is more general than "Delayed-Action Preparations".

Chemicals and Drugs [D]
Pharmaceutical Preparations [D26]
Dosage Forms [D26.255]
Delayed-Action Preparations [D26.255.210]
Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Delivery Systems [E02.319.300]
Delayed-Action Preparations [E02.319.300.253]

Below are MeSH descriptors whose meaning is related to "Delayed-Action Preparations".

Below are MeSH descriptors whose meaning is more specific than "Delayed-Action Preparations".

Delayed-Action Preparations
Drug Implants
Tablets, Enteric-Coated

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Delayed-Action Preparations" by people in this website by year, and whether "Delayed-Action Preparations" was a major or minor topic of these publications.

Bar chart showing 76 publications over 23 distinct years, with a maximum of 7 publications in 2017 and 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1999	0	1	1
2004	0	1	1
2005	1	1	2
2006	0	2	2
2007	1	2	3
2008	0	4	4
2009	0	3	3
2010	0	3	3
2012	0	2	2
2013	0	3	3
2014	0	5	5
2015	0	4	4
2016	2	2	4
2017	1	6	7
2018	3	4	7
2019	2	3	5
2020	2	2	4
2021	1	4	5
2022	0	4	4
2023	0	1	1
2024	1	2	3
2025	0	2	2

Below are the most recent publications written about "Delayed-Action Preparations" by people in Profiles.

Nunes AP, Jung H, Yuan Y, Baek J, Pawasauskas J, Hume AL, Liu SH, Lapane KL. Comparative Safety of Short-Acting Opioid Dose Escalation and Long-Acting Opioid Initiation in Nursing Home Residents. J Am Geriatr Soc. 2025 May; 73(5):1517-1527.

View in: PubMed
Liu H, Liu Y, Peng S, Zhou L, McClements DJ, Fang S, Liu W. Colonic delivery and controlled release of curcumin encapsulated within plant-based extracellular vesicles loaded into hydrogel beads. Food Res Int. 2025 Feb; 202:115540.

View in: PubMed
Dang MT, Le YN, Naz-McLean S, Vo NTT, Do PT, Doan LTT, Do NT, Nguyen MT, Phan AH, Dziuban EJ, Bhatia R, Cosimi L, Phan HTT, Pollack TM. Anticipated facilitators and barriers for long-acting injectable antiretrovirals as HIV treatment and prevention in Vietnam: a qualitative study among healthcare workers. BMC Infect Dis. 2024 Dec 25; 24(1):1462.

View in: PubMed
Stopka TJ, Rottapel R, Friedmann PD, Pivovarova E, Evans EA. Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study. Addict Sci Clin Pract. 2024 Sep 12; 19(1):68.

View in: PubMed
Christine PJ, Lodi S, Hsu HE, Bovell-Ammon B, Yan S, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz J, Walley AY, Larochelle MR. Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder. Addiction. 2024 07; 119(7):1313-1321.

View in: PubMed
Liang X, Chen L, McClements DJ, Peng X, Xu Z, Meng M, Jin Z. Bioactive delivery systems based on starch and its derivatives: Assembly and application at different structural levels. Food Chem. 2024 Jan 30; 432:137184.

View in: PubMed
Naeem S, Barkat K, Shabbir M, Khalid I, Anjum I, Shamshad N, Mehmood Y, Khan DH, Badshah SF, Syed MA, Afzal S, Abdullah Z. Fabrication of pH responsive hydrogel blends of chondroitin sulfate/pluronic F-127 for the controlled release of ketorolac: its characterization and acute oral toxicity study. Drug Dev Ind Pharm. 2022 Nov; 48(11):611-622.

View in: PubMed
Han JR, Wang Q, Yi LX, Li P, Gu Q, Xiao H, Zhu BW, Wu HT. Improving the in vitro and in vivo bioavailability of pterostilbene using Yesso scallop gonad protein isolates-epigallocatechin gallate (EGCG) conjugate-based emulsions: effects of carrier oil. Food Funct. 2022 Sep 22; 13(18):9544-9558.

View in: PubMed
Meng Y, Qiu C, Li X, McClements DJ, Sang S, Jiao A, Jin Z. Polysaccharide-based nano-delivery systems for encapsulation, delivery, and pH-responsive release of bioactive ingredients. Crit Rev Food Sci Nutr. 2024; 64(1):187-201.

View in: PubMed
Martin RA, Berk J, Rich JD, Kang A, Fritsche J, Clarke JG. Use of long-acting injectable buprenorphine in the correctional setting. J Subst Abuse Treat. 2022 11; 142:108851.

View in: PubMed

People

Explore

Similar Concepts

Top Journals